About Arpeggio Biosciences
Arpeggio Biosciences is a biotechnology company that uses its AI-driven chemotranscriptomics platform to discover and develop novel small-molecule therapeutics for complex diseases like cancer. The company advances its own pipeline of drug candidates while also partnering with pharmaceutical and biotech firms to provide R&D services that accelerate their discovery programs.
Company Classification
Customer Types
B2B
Business Models
ServicesLicensingProducts
Product & Service Types
AI-powered drug discovery platformsTherapeutic candidate developmentContract research (CRO) services
Customers
| Customer | Success Story | Source |
|---|---|---|
| Arpeggio routinely screens cysteine-focused covalent small molecules based on AstraZeneca's insights. | ||
| Partnered with Arpeggio Bio to validate their drug development platform. | ||
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Another Company | Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. | Source |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos